跳至主要内容
临床试验/NCT01978249
NCT01978249终止不适用

A Randomized, Prospective, Multicenter Study for the Role of Primary Tumor Resection in Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastasis

Yonsei University13 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2013年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
52
试验地点
13
主要终点
Comparison of the overall survival between patients who underwent primary tumor resection and patients who received chemotherapy without primary tumor resection

研究概览

简要总结

Short description for lay public, include brief statement of the study hypothesis

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age : between 20 and 90 years old
  • Histologically confirmed adenocarcinoma of the colon or the upper rectum
  • Patients with resectable primary colon or upper rectal cancer and unresectable metastatic lesions.
  • Patients with no primary cancer related symptoms.
  • ECOG performance status of 0 - 2
  • Appropriate organ functions (hepatic transaminases - less than 5 times the normal range; bilirubin - less than 2 times the normal range; creatinine serum - less than 1.5 times the normal range; thrombocyte - more than 100,000/µl; neutrophil - more than 1,500/µl)
  • ASA score of < 3
  • An informed consent form has been signed by the patient.

排除标准

  • The patient received adjuvant chemotherapy within the past 6 months.
  • The patient received chemotherapy for metastatic colon cancer.
  • The patient was planning to have curative surgery for the metastatic lesions.
  • The primary cancer is unresectable.
  • Patients with peritoneal carcinomatosis.
  • Patients with mid and low rectal cancer (< 10cm)
  • Patients with primary tumor related complications such as intestinal obstruction, intractable bleeding, and perforation, that needs to be treated.
  • ASA score of > 4
  • The patient has chronic hepatitis or cirrhosis. An asymptomatic HBV or HCV carrier can participate.
  • Patients with an active infection, which need antibiotic therapy, during the randomization period.
  • Pregnant or breastfeeding women
  • Patients who were enrolled in another clinical trial during the time of enrollment (within the 28 day randomization period).
  • Patients with another different malignant tumor during the past 5 years. Patients with treated non-melanoma skin cancer or cervical cancer can be enrolled in this study.

研究组 & 干预措施

Chemotherapy first without primary tumor resection

Experimental

Patients will receive chemotherapy first without primary tumor resection.

干预措施: Systemic chemotherapy (Procedure)

Primary tumor resection followed by chemotherapy

Active Comparator

Patients will receive primary tumor resection followed by chemotherapy.

干预措施: primary tumor resection (PTR) (Procedure)

结局指标

主要结局

Comparison of the overall survival between patients who underwent primary tumor resection and patients who received chemotherapy without primary tumor resection

时间窗: 2 years after allocation

Comparison of the overall survival between patients who underwent primary tumor resection followed by chemotherapy and patients who received chemotherapy without primary tumor resection in stage IV colorectal cancer patients with unresectable metastasis.

次要结局

  • Analysis of primary tumor related complications in the chemotherapy group and postoperative complications in the primary tumor resection followed by the chemotherapy group.(2 years after allocation)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验

A Randomized, Prospective, Multicenter Study for the... | 临床试验